Glenda Gray’s fierce fight for science, the COVID-19 ruckus, and the bathroom row about HIV drugs

After a decade at the helm of the country’s primary health research funder, Professor Glenda Gray will focus again on doing the science. She tells Spotlight’s Biénne Huisman about her childhood, her passion for research, administering multi-million dollar grants, and a heated argument in the bathroom with an ANC bigwig.

Read More

OPINION: The billions allocated for infrastructure require more progressive procurement systems and oversight

Spending on public sector infrastructure over the 2023 medium-term expenditure framework (MTEF) is estimated at R903 billion and the health sector accounts for 5% of this. The well-documented poor maintenance and oversight of projects, also in the health sector, will require close monitoring of trends across the public sector, particularly where procurement and contracting is concerned, writes Zukiswa Kota.

Read More

Health in 2021: Another tumultuous year in under a thousand words

It wasn’t rocket science when we predicted at the start of 2021 that South Africa’s biggest challenge this year would be to get COVID-19 shots into as many arms as possible. But the way it has played out with multiple setbacks and scrambling problem-solving is not something anyone could have predicted. In fewer than a thousand words, Spotlight editor Marcus Low takes a look back at a tumultuous year in health in South Africa.

Read More

In-depth: Dirty laundry at Eastern Cape hospitals and the plan to deal with it

Some staff members at Livingstone Hospital in the Eastern Cape say old laundry machines and staff shortages are creating backlogs in getting clean linen, towels, and hospital gowns to patients. Patients, in turn, say they have to sleep on bare and soiled mattresses often with no bedding or dirty linen. Luvuyo Mehlwana reports on the situation, its implications for infection control, and the province’s plans to deal with it.

Read More

Assessing Dr Zweli Mkhize’s two years as Health Minister

Last night President Cyril Ramaphosa announced that Dr Zweli Mkhize had resigned as South Africa’s Minister of Health after eight weeks on special leave. Although Mkhize will primarily be remembered for the Digital Vibes scandal that caused his downfall, a lot more happened over the last two years. Spotlight editor Marcus Low asks what we can learn from Mkhize’s time as health minister and tries to make sense of some of the contradictions.

Read More

Opinion: The President must rise above petty politics and appoint a Health Minister fit to fight our current crisis

While the Digital Vibes scandal has no doubt presented President Cyril Ramaphosa with a massive headache, it has also presented him with an opportunity. In appointing a new Minister of Health, he can set South Africa’s COVID-19 response on a sounder footing. We should soon know whether this is an opportunity he is ready to take, writes Spotlight editor Marcus Low.

Read More

Corruption and ministerial powers centre stage at NHI hearings

Health Minister Dr Zweli Mkhize this week provided an update on investigations into a multimillion-rand NHI communications contract mired in controversy. That same morning, MPs in Parliament were again reminded of how critical an independent National Health Insurance Board will be. One organisation proposed an additional NHI corruption-fighting unit. Alicestine October has the latest from in and outside of Parliament.

Read More

Behind the scenes: How the first 500 000 vaccine doses administered in SA were secured

When South Africa’s rollout of the AstraZeneca vaccine was put on hold in early February, a scramble ensued to ensure healthcare workers could be protected. Chris Bateman spoke to Professor Glenda Gray about the behind-the-scenes negotiations that helped secure 500 000 doses of the Johnson & Johnson vaccine – almost all of which have now been used in the Sisonke study.

Read More

Editorial: Pieces finally slotting into place for mass vaccination in SA

Within the next month or so we will be switching gears from the comparatively small-scale trial run of Sisonke to a full-on mass vaccination programme. As with the onset of a new wave of infections, this presents a dramatic shift in the pandemic and our response to it – although in this case, the shift is finally a good thing, writes Spotlight editor Marcus Low.

Read More

1 2 3 5